FDA clears exoskeleton for stroke rehabilitation
Вставка
- Опубліковано 22 січ 2023
- The U.S. Food and Drug Administration has cleared Wandercraft's self-balancing exoskeleton for use in stroke rehabilitation. In July 2021, Reuters was given a first-hand demonstration of the possibilities wearable exoskeletons can have for people with disabilities.
#Exoskeleton #Rehab #Wandercraft #FDA #Science #Technology #News #Reuters #newsfeed
Subscribe: smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: www.reuters.com/
Follow Reuters on Facebook: / reuters
Follow Reuters on Twitter: / reuters
Follow Reuters on Instagram: reuters?hl=en - Наука та технологія